These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 22126844)

  • 1. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.
    Chang YF; Lo AC; Tsai CH; Lee PY; Sun S; Chang TH; Chen CC; Chang YS; Chen JR
    Palliat Med; 2013 Feb; 27(2):185-91. PubMed ID: 22126844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
    Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
    Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
    Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity after insertion of totally implantable venous access ports in oncological patients: results of a retrospective clinical study.
    Aspalter M; Lechner M; Linni K; Hitzl W; Hölzenbein T; Ofner D; Emmanuel K
    Am Surg; 2014 Feb; 80(2):204-7. PubMed ID: 24480224
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between risk of bloodstream infection and duration of use of totally implantable access ports and central lines: a 24-month study.
    Yoshida J; Ishimaru T; Kikuchi T; Matsubara N; Asano I
    Am J Infect Control; 2011 Sep; 39(7):e39-43. PubMed ID: 21652113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients.
    Kakkos A; Bresson L; Hudry D; Cousin S; Lervat C; Bogart E; Meurant JP; El Bedoui S; Decanter G; Hannebicque K; Regis C; Hamdani A; Penel N; Tresch-Bruneel E; Narducci F
    Eur J Surg Oncol; 2017 Apr; 43(4):689-695. PubMed ID: 27889197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with an implantable vascular access device.
    Dillon PA; Foglia RP
    J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications associated with the placement of subcutaneous central venous access port devices: reasons for removal and complications observed].
    Danno K; Ohnishi T; Watanabe A; Ueda M; Yanagawa T; Kim C; Fujita S; Fujita J; Yoshida T; Tono T; Monden T; Imaoka S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2404-6. PubMed ID: 23268092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical technique for totally implantable access ports (TIAP) needs improvement: a multivariate analysis of 400 patients.
    Seiler CM; Frohlich BE; Dorsam UJ; Kienle P; Buchler MW; Knaebel HP
    J Surg Oncol; 2006 Jan; 93(1):24-9. PubMed ID: 16353193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of outcomes and survivals for two central venous access port systems.
    Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
    J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
    Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
    Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
    Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
    Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incidence of Totally Implantable Venous Access Devices Insertion and the Associated Abnormalities in Patients With Cancer Revealed in
    Kao PF; Weng JH; Tyan YS; Yang SF; Tsao TC
    Acad Radiol; 2017 Dec; 24(12):1588-1595. PubMed ID: 28784412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.